Discussions

Antiviral peptides as promising therapeutics against SARS-CoV-2​ are gaining attention in the fight against COVID-19. These peptides, known for their broad-spectrum antiviral activities, can interfere with viral entry, replication, or assembly, thereby hindering the virus's life cycle. In the context of SARS-CoV-2, the virus responsible for the COVID-19 pandemic, antiviral peptides offer a novel approach to treatment by targeting specific viral proteins or host cell receptors critical for infection. As promising therapeutics, these peptides are being extensively studied for their efficacy, safety, and potential to complement existing antiviral drugs, ultimately contributing to more effective management and control of the pandemic.